- Home
- KALA vs NMTC Comparison
KALA vs NMTC Comparison
Compare KALA & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- NMTC
- Stock Information
- Founded
- KALA 2009
- NMTC 2009
- Country
- KALA United States
- NMTC United States
- Employees
- KALA N/A
- NMTC N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- KALA Health Care
- NMTC Health Care
- Exchange
- KALA Nasdaq
- NMTC Nasdaq
- Market Cap
- KALA 26.2M
- NMTC 33.8M
- IPO Year
- KALA 2017
- NMTC N/A
- Fundamental
- Price
- KALA $7.38
- NMTC $0.83
- Analyst Decision
- KALA Strong Buy
- NMTC Strong Buy
- Analyst Count
- KALA 3
- NMTC 1
- Target Price
- KALA $14.00
- NMTC $1.45
- AVG Volume (30 Days)
- KALA 204.0K
- NMTC 221.0K
- Earning Date
- KALA 08-05-2025
- NMTC 08-13-2025
- Dividend Yield
- KALA N/A
- NMTC N/A
- EPS Growth
- KALA N/A
- NMTC N/A
- EPS
- KALA N/A
- NMTC N/A
- Revenue
- KALA N/A
- NMTC $5,758,777.00
- Revenue This Year
- KALA N/A
- NMTC $157.28
- Revenue Next Year
- KALA N/A
- NMTC $41.79
- P/E Ratio
- KALA N/A
- NMTC N/A
- Revenue Growth
- KALA N/A
- NMTC 54.53
- 52 Week Low
- KALA $2.92
- NMTC $0.40
- 52 Week High
- KALA $11.20
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- KALA 74.24
- NMTC 55.86
- Support Level
- KALA $5.35
- NMTC $0.81
- Resistance Level
- KALA $8.49
- NMTC $1.05
- Average True Range (ATR)
- KALA 0.79
- NMTC 0.08
- MACD
- KALA 0.24
- NMTC -0.00
- Stochastic Oscillator
- KALA 97.13
- NMTC 40.28
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.